MBP1: a novel mutant p53-specific protein partner with oncogenic properties

Related Experiment Video

Updated: Oct 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

W M Gallagher1, M Argentini, V Sierra

  • 1Oncology Department, Rhône-Poulenc Rorer, CRVA, Vitry-sur-Seine, France.

Oncogene
|June 25, 1999
PubMed

Insights

Researchers discovered Mutant p53-Binding Protein 1 (MBP1), a novel fibulin family member that interacts with mutant p53. Overexpression of MBP1 enhances neoplastic transformation and tumor growth, suggesting its role as a candidate oncogene.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The p53 protein is a critical tumor suppressor.
  • Mutations in p53 are common in human cancers and can lead to altered protein function, including gain-of-function effects.
  • Identifying proteins that interact with mutant p53 is crucial for understanding cancer development.

Purpose of the Study:

  • To identify novel interacting partners of mutant p53.
  • To characterize the function and binding properties of a newly identified mutant p53-binding protein.
  • To investigate the potential oncogenic role of this novel protein.

Main Methods:

  • Yeast two-hybrid screening using a mutant p53 bait.
  • Co-immunoprecipitation in mammalian cells.
  • mRNA expression analysis during mouse embryonic development and in adult tissues.
  • Assessment of neoplastic transformation and tumor cell growth rates upon ectopic protein overexpression.

Main Results:

  • A novel protein, Mutant p53-Binding Protein 1 (MBP1), was identified as a mutant p53 interactor.
  • MBP1 belongs to the fibulin gene family and shows differential mRNA expression.
  • MBP1 preferentially binds to structural mutants of p53 over wild-type p53.
  • Ectopic overexpression of MBP1 significantly enhanced neoplastic transformation and tumor cell growth.

Conclusions:

  • MBP1 is a novel fibulin family member that specifically interacts with mutant p53.
  • MBP1's ability to enhance transformation and tumor growth suggests it is a candidate oncogene.
  • MBP1 may contribute to the gain-of-function phenotype observed in certain p53 mutants.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.